이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Mach7 Technologies 배당금

배당금 기준 확인 0/6

Mach7 Technologies 배당금을 지급한 기록이 없습니다.

주요 정보

n/a

배당 수익률

n/a

지급 비율

업계 평균 수익률	1.1%
다음 배당금 지급일	n/a
전 배당일	n/a
주당 배당금	n/a
주당 순이익	-AU$0.023
3년 후 배당 수익률 예측	0%

최근 배당금 업데이트

업데이트 없음

Recent updates

Mach7 Technologies Limited (ASX:M7T) Analysts Are More Bearish Than They Used To Be

Jan 29

We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow

Apr 28

An Intrinsic Calculation For Mach7 Technologies Limited (ASX:M7T) Suggests It's 47% Undervalued

Oct 24

Are Investors Undervaluing Mach7 Technologies Limited (ASX:M7T) By 37%?

Jun 23

Is Mach7 Technologies Limited (ASX:M7T) Potentially Undervalued?

May 19

Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 47% Undervaluation?

Nov 10

Mach7 Technologies Limited's (ASX:M7T) Analyst Just Slashed This Year's Estimates

Jul 27

Upgrade: The Latest Revenue Forecasts For Mach7 Technologies Limited (ASX:M7T)

Feb 19

The Mach7 Technologies (ASX:M7T) Share Price Is Up 303% And Shareholders Are Delighted

Jan 27

Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 46% Undervaluation?

Dec 06

결제의 안정성과 성장

배당금 데이터 가져오기

안정적인 배당: 과거에 M7T 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.

배당금 증가: M7T 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.

시장 대비 배당 수익률

Mach7 Technologies 시장 대비 배당 수익률

M7T 배당 수익률은 시장과 어떻게 비교되나요?
세그먼트	배당 수익률
회사 (M7T)	n/a
시장 하위 25% (AU)	2.7%
시장 상위 25% (AU)	6.6%
업계 평균 (Healthcare Services)	1.1%
3년 후 애널리스트 예측 (M7T)	0%

주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 M7T 의 배당 수익률을 평가할 수 없습니다.

고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 M7T 의 배당 수익률을 평가할 수 없습니다.

주주에 대한 수익 배당금

수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 M7T 의 지급 비율을 계산하기에는 데이터가 부족합니다.

주주에 대한 현금 배당금

현금 흐름 범위: M7T 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.

Mach7 Technologies 배당금

배당금 기준 확인 0/6

주요 정보

최근 배당금 업데이트

Recent updates

Now 24% undervalued after recent price drop

Now 25% undervalued after recent price drop

Now 25% undervalued after recent price drop

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Mach7 Technologies Limited to Report Q3, 2024 Results on Apr 24, 2024

Mach7 Technologies Limited to Report First Half, 2024 Results on Feb 29, 2024

Mach7 Technologies Limited (ASX:M7T) Analysts Are More Bearish Than They Used To Be

Consensus EPS estimates fall by 120%

Forecast breakeven date pushed back to 2026

Mach7 Technologies Limited to Report Q2, 2024 Results on Jan 31, 2024

Price target decreased by 7.6% to AU$1.23

Mach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business

Insufficient new directors

Mach7 Technologies Limited Appoints Rebecca Thompson as Director

Independent Non-Executive Director exercised options to buy AU$158k worth of stock.

Consensus EPS estimates upgraded to AU$0.0045 loss, revenue downgraded

Mach7 Technologies Limited to Report Q1, 2024 Results on Oct 31, 2023

New minor risk - Market cap size

Price target decreased by 9.7% to AU$1.33

Is Now The Time To Look At Buying Mach7 Technologies Limited (ASX:M7T)?

CEO, MD & Director exercised options and sold AU$65k worth of stock

Mach7 Technologies Limited Announces Board Changes, Effective 16 November 2023

Estimating The Fair Value Of Mach7 Technologies Limited (ASX:M7T)

Forecast breakeven date pushed back to 2025

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Financial data availability

Mach7 Technologies Limited to Report Fiscal Year 2023 Results on Aug 31, 2023

Mach7 Technologies Limited, Annual General Meeting, Nov 16, 2023

Mach7 Technologies Limited to Report Q4, 2023 Results on Jul 31, 2023

Price target increased by 13% to AU$1.49

Independent Non-Executive Chairman exercised options to buy AU$140k worth of stock.

Why Mach7 Technologies Limited (ASX:M7T) Could Be Worth Watching

Now 21% undervalued after recent price drop

We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow

Now 20% undervalued after recent price drop

First half 2023 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2022)

Consensus EPS estimates upgraded to AU$0.009 loss, revenue downgraded

Mach7 Technologies Limited Announces Change of Company Secretary

Mach7 Technologies Limited Provides Revenue Guidance for the Year 2023

Mach7 Technologies Limited Announces Executive Changes, Effective January 1, 2023

Consensus forecasts updated

An Intrinsic Calculation For Mach7 Technologies Limited (ASX:M7T) Suggests It's 47% Undervalued

Mach7 Technologies Limited, Annual General Meeting, Nov 17, 2022

Consensus forecasts updated

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased to AU$1.27

Mach7 Technologies Limited to Report Q4, 2022 Results on Aug 29, 2022

Mach7 Technologies Limited to Report Q4, 2022 Results on Jul 21, 2022

Are Investors Undervaluing Mach7 Technologies Limited (ASX:M7T) By 37%?

Is Mach7 Technologies Limited (ASX:M7T) Potentially Undervalued?

Price target decreased to AU$1.38

Price target decreased to AU$1.38

Consensus forecasts updated

Consensus forecasts updated

First half 2022 earnings: EPS and revenues miss analyst expectations

Mach7 Technologies Limited to Report First Half, 2022 Results on Feb 28, 2022

Mach7 Technologies Limited to Report Q2, 2022 Results on Jan 31, 2022

Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 47% Undervaluation?

Company Secretary Jennifer Pilcher has left the company

Mach7 Technologies Limited Provides Earning Guidance for the Calendar Year 2021

Mach7 Technologies Limited's (ASX:M7T) Analyst Just Slashed This Year's Estimates

Price target decreased to AU$1.56

First half 2021 earnings released: AU$0.031 loss per share (vs AU$0.004 profit in 1H 2020)

Upgrade: The Latest Revenue Forecasts For Mach7 Technologies Limited (ASX:M7T)

Price target raised to AU$1.68

Analysts update estimates

Mach7 Technologies Limited to Report First Half, 2021 Results on Feb 18, 2021

New 90-day high: AU$1.57

Mach7 Technologies Limited Provides Update on Its Project with the Hospital Authority of Hong Kong

The Mach7 Technologies (ASX:M7T) Share Price Is Up 303% And Shareholders Are Delighted

Mach7 Technologies Limited Wholly-Owned Subsidiary Signs a Contract Amendment with Adventist Health System

New 90-day high: AU$1.34

Mach7 Technologies Limited Appoints Philippe Houssiau as Non-Executive Director, Effective 1 January 2021